The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Income Before Tax

Profit after all operating and non-operating items but before income tax.

The Oncology Institute, Inc.NASDAQ: TOI

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$2.49M, compared with -$19.59M a year earlier. Trailing-twelve-month income before tax was -$43.64M.

Context

  • Income before tax amounted to 12.1% of revenue in FY2025, down 4.4 pp from a year earlier.
  • Income before tax grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near -$2.49M or moves back toward the trailing-twelve-month quarterly average of -$10.91M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.49M+66.8% QoQ
Last fiscal yearDec 2025
-$60.74M+6.1% YoY
LTMMar 2026
-$43.64M+32.2% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+87.3%——
1 year+6.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(60.74M) USD
Year-over-year change
+6.1%

Income Before Tax vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +32.2% is the highest of 10, against a peer median of -32.8%.
  • Income before tax amounts to 8.0% of revenue for TOI, versus a peer median of 16.3%.
TOI Competitors
Income Before Tax for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 154M PEN-32.8%—3.4%
KIDSOrthoPediatrics Corp.LTM Mar 2026-$39.58M USD+5.9%—16.3%
EOLSEvolus, Inc.LTM Mar 2026-$42.56M USD+23.3%—14.1%
TOIThe Oncology Institute, Inc.LTM Mar 2026-$43.64M USD+32.2%—8.0%
CBLLCeriBell, Inc.LTM Mar 2026-$60.37M USD-35.7%—63.5%
TMCITreace Medical Concepts, Inc.LTM Mar 2026-$61.04M USD-15.2%—29.4%
CCRNCross Country Healthcare, Inc.LTM Mar 2026-$86.35M USD-311.4%—8.6%
SNDASonida Senior Living, Inc.LTM Mar 2026-$100.45M USD-133.2%—24.4%
AUTLAutolus Therapeutics plcLTM Mar 2026-$288.22M USD-23.0%—311.3%
AGLAgilon Health, Inc.LTM Mar 2026-$372.46M USD-46.9%—6.4%
Peer median (excluding TOI) —-32.8%—16.3%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.